Buy Omnipaque 300mg/50ml Iohexol USP

Omnipaque 300mg/50ml is a non-ionic, low-osmolality contrast agent used in diagnostic imaging. Suitable for CT scans, angiograms, and other radiographic procedures. Provides clear visualization of blood vessels and organs. Store at ambient temperature in a secure location.

Strength

300mg/50ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

GE Healthcare Shanghai Co Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Omnipaque 300mg/50ml is primarily used as a contrast medium in medical imaging procedures such as CT scans, angiograms, and urography. It helps enhance the visibility of blood vessels, organs, and tissues during radiographic examinations. This product is intended for diagnostic purposes only and should be administered by healthcare professionals.

Side Effects

After administration, Omnipaque 300mg/50ml helps highlight internal structures, making them more visible on X-ray images. Patients may experience a warm sensation or metallic taste temporarily. These effects are normal and typically subside quickly. The contrast agent is excreted through the kidneys over time.

Precautions & Warnings

Omnipaque 300mg/50ml should be handled with care and used only as directed by a healthcare provider. Patients with known allergies to iodinated contrast agents should avoid this product. Ensure proper hydration before and after administration to support kidney function. Keep out of reach of children and pets.

Avoid Interactions

Concurrent use of certain medications, such as metformin or nephrotoxic drugs, may require monitoring or adjustment. Alcohol consumption may increase the risk of adverse effects. Always inform your healthcare provider about all medications and supplements you are taking before receiving Omnipaque 300mg/50ml.

References

Frequently Asked Questions

It is a contrast agent used in CT scans, angiograms, and other imaging procedures to enhance visibility of internal structures.

It is administered intravenously by a healthcare professional during diagnostic imaging procedures.

Consult your healthcare provider, as kidney function may affect the safety of iodinated contrast agents.

Temporary warmth or metallic taste may occur; these effects are generally mild and short-lived.

Use during pregnancy should be determined by a healthcare provider based on potential benefits and risks.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.